Read + Share
Font A, Mellado B, Climent MA, Virizuela JA, et al. Phase II trial of afatinib in patients with advanced urothelial carcinoma with
genetic alterations in ERBB1-3 (LUX-Bladder 1). Br J Cancer 2024;130:434-441.
PMID: 38102226
|
 |
|
Font A, Mellado B, Climent MA, Virizuela JA, et al. Phase II trial of afatinib in patients with advanced urothelial carcinoma with
genetic alterations in ERBB1-3 (LUX-Bladder 1). Br J Cancer 2024;130:434-441.
PMID: 38102226
|
|
|
|